Pittsburgh, PA, United States of America

Keith Olson

This inventor holds 1 USPTO granted patent. Top assignee: Cellomics, Inc.. Active years: 2004.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 34(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Keith Olson - Innovator in Cell-Based Screening Technology

Introduction

Keith Olson is a notable inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of cell-based screening technology. His work focuses on developing systems and methods that enhance the analysis of cellular environments and activities.

Latest Patents

Keith Olson holds a patent for a "System for cell-based screening." This invention provides systems, methods, screens, reagents, and kits for optical system analysis of cells. The primary purpose of this technology is to rapidly determine the distribution, environment, or activity of fluorescently labeled reporter molecules in cells. This innovation is particularly useful for screening large numbers of compounds that specifically affect particular biological functions.

Career Highlights

Keith Olson is associated with Cellomics, Inc., where he applies his expertise in cell-based technologies. His work has contributed to advancements in the understanding of cellular functions and the development of new screening methods.

Collaborations

Some of his notable coworkers include Gary L Bright and Kenneth A Giuliano. Their collaborative efforts have furthered research and innovation in the field of cell-based screening.

Conclusion

Keith Olson's contributions to cell-based screening technology exemplify the impact of innovative thinking in scientific research. His patent and work at Cellomics, Inc. highlight the importance of developing advanced methods for understanding biological functions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…